Drugs / Steroids
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT00321113 | Sep 2004 → Mar 2008 | — | Astellas Pharma Inc | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03192657 Background | Jul 2017 → Jun 2019 | dermatomyositis, interstitial lung disease | RenJi Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | steroids | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00321113 ↗ |